首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1562405

到 2030 年北美肠外营养市场预测 - 区域分析 - 按营养类型和最终用户

North America Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 82 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美肠外营养市场估值为30.1206亿美元，预计2030年将达48.0531亿美元；预计2022年至2030年复合年增长率为6.0%。

胃肠道疾病盛行率上升推动北美肠外营养市场

克罗恩病、肠阻塞、溃疡性结肠炎、短肠症候群、显微镜下结肠炎和胃癌是胃肠道疾病的一些例子。根据 2021 年 1 月发布的“罗马基金会全球研究结果，功能性胃肠道疾病的全球盛行率和负担”，功能性胃肠道疾病影响了全球超过 40% 的人。

根据2019年全球疾病负担研究，2019年全球记录了约490万例发炎性肠道疾病（IBD）病例。溃疡性结肠炎和克隆氏症是两种常见的 IBD。克罗恩病是一种复杂的慢性疾病，主要影响消化系统。它是北美和欧洲最常见的疾病。根据 2020 年发表的题为「了解短肠症候群：现况与未来展望」的文章，过去 40 年来，短肠症候群 (SBS) 的盛行率增加了两倍多。在美国，盛行率约为每百万人 30 例，在欧洲约为每百万人 1.4 例。

患有胃肠道疾病的患者营养恶化的风险较高，因为他们被要求在接受诊断测试之前禁食。他们也可能因治疗性饮食限製而面临营养恶化，以及厌食症或营养需求改变引起的食慾不振，这可能是疾病本身造成的。因此，对于无法摄取食物的胃肠道疾病患者，建议进行医学营养治疗。此外，优选肠胃外途径来为它们提供必需的营养素。有些人可能不适合插管，这使得满足他们的卡路里和营养需求变得困难。在这种情况下，优选肠外营养，以确保他们的身体保持水分并满足维持身体健康和功能所需的热量和其他营养摄取量。当患者因被诊断出患有影响胃肠道的癌症和慢性疾病等疾病而无法满足营养需求时，就需要肠外营养。对于大多数患有严重 SBS 的患者来说，这种类型的营养是高度首选的治疗选择。因此，胃肠道疾病的日益普及推动了肠外营养市场的发展。

北美肠外营养市场概况

癌症、心臟病和其他慢性疾病是美国残疾和死亡的主要原因。根据国家慢性病预防和健康促进中心的数据，该国每 10 人中有 6 人被诊断出患有至少一种慢性病。此外，美国医院协会估计约有 1.33 亿人患有至少一种慢性病，预计到 2030 年这一数字将达到 1.7 亿人根据 2019 年 1 月发表的题为「肠外营养趋势」的文章；在美国，平均每年约有 34,000 名患者接受肠外营养 (PN)。肠内管饲可用于治疗 350 多种儿童疾病。

美国政府正努力透过各种措施让人们了解肠内和肠外营养。例如，饲管意识基金会提高了人们对采用饲管作为救生医疗干预措施的认识，并帮助管饲儿童的父母。该基金会于 2019 年 2 月 4 日至 2 月 8 日庆祝了一年一度的饲管意识週。期内的市场成长。例如，2022 年 3 月，Fresenius Kabi 的 SMOFlipid 脂质注射乳液获得 FDA 批准。该乳剂是第一个也是唯一一个适合所有年龄层需要肠外营养的患者的四油脂肪乳剂。

因此，需要医疗营养的慢性疾病发病率不断上升、政府努力提高人们对肠外营养重要性的认识以及主要参与者的战略倡议支持了美国肠外营养市场的增长。

北美肠外营养市场收入及 2030 年预测（百万美元）

北美肠外营养市场细分

北美肠外营养市场根据营养素类型、最终用户和国家进行细分。根据营养类型，北美肠外营养市场分为单剂量胺基酸溶液、肠外脂肪乳、碳水化合物、微量元素以及维生素和矿物质。 2022 年，单剂量胺基酸溶液细分市场占据最大市场份额。

依最终用户划分，北美肠外营养市场分为医院、诊所等。 2022 年，医院细分市场占据最大市场份额。

依国家划分，北美肠外营养市场分为美国、加拿大和墨西哥。 2022年，美国在北美肠外营养市场占有率中占据主导地位。

ICU Medical Inc、Grifols SA、辉瑞公司、大冢製药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是北美肠外营养领域的一些领先参与者市场。

Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and gastric cancer are a few examples of gastrointestinal diseases. According to the "Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study," published in January 2021, functional gastrointestinal disorders have affected over 40% of people across the globe.

Based on the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019. The US (762,890) registered the highest number of cases, with prevalence of 245.3 cases per 100,000 people, respectively. Ulcerative colitis and Crohn's disease are two of the commonly diagnosed IBDs. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. It is the most common disease in North America and Europe. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of short bowel syndrome (SBS) has increased by more than twofold in the last 40 years. The prevalence was ~30 cases per million in the US and approximately 1.4 cases per million in Europe.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They might also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Hence, medical nutrition is recommended for gastrointestinal disease patients as they are unable to ingest food. Further, the parenteral routes are preferred to provide them with essential nutrients. Some people might not show compatibility with tube insertion, which makes meeting their calorie and nutrient needs difficult. In such cases, parenteral nutrition is preferred to ensure their bodies remain hydrated and meet the calorie and other nutrient intake required to maintain physical well-being and function. Parenteral nutrition is indicated when patients cannot meet their nutritional needs as they are diagnosed with diseases such as cancer and chronic diseases, which affect the gastrointestinal tract. This type of nutrition is highly preferred as a therapy option for most patients suffering from severe SBS. Therefore, the growing prevalence of gastrointestinal diseases drives the parenteral nutrition market.

North America Parenteral Nutrition Market Overview

Cancer, heart disease, and other chronic diseases are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country are diagnosed with at least one chronic disease. Additionally, the American Hospital Association estimates that ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. According to an article titled "Trends in Parenteral Nutrition," published in January 2019; on average, ~34,000 patients receive parenteral nutrition (PN) annually in the US. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

The US government is working on making people aware of enteral and parenteral nutrition through initiatives. For instance, the Feeding Tube Awareness Foundation creates awareness about the adoption of feeding tubes as a lifesaving medical intervention and helps parents of tube-fed children. The foundation celebrated the annual Feeding Tube Awareness Week from February 4, 2019, to February 8, 2019. In addition, a significant rise in US Food and Drug Administration (FDA) approvals of products by market players is likely to play a key role in the market growth during the forecast period. For instance, in March 2022, Fresenius Kabi received FDA approval for its SMOFlipid lipid injectable emulsion. The emulsion is the first and only four-oil lipid emulsion for patients of all ages requiring parenteral nutrition.

Therefore, the growing incidence of chronic diseases requiring medical nutrition, government efforts to raise awareness about the importance of parenteral nutrition, and strategic initiatives by key players support the growth of the parenteral nutrition market in the United States.

North America Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

North America Parenteral Nutrition Market Segmentation

The North America parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the North America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins & minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the North America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the North America parenteral nutrition market is segmented into the US, Canada, and Mexico. The US dominated the North America parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the North America parenteral nutrition market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 New Product Developments by Companies
4.4 Future Trends
- 4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis

5. Parenteral Nutrition Market - North America Market Analysis

5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. North America Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview
6.2 Single Dose Amino Acid Solution
- 6.2.1 Overview
- 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
- 6.3.1 Overview
- 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
- 6.4.1 Overview
- 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
- 6.5.1 Overview
- 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
- 6.6.1 Overview
- 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Parenteral Nutrition Market Analysis - by End User

7.1 Overview
7.2 Hospitals
- 7.2.1 Overview
- 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
- 7.3.1 Overview
- 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Parenteral Nutrition Market - Country Analysis

8.1 North America: Parenteral Nutrition Market
- 8.1.1 North America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 United States: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.1 Overview
    - 8.1.1.1.2 United States: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.3 United States: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.1.4 United States: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.2 Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.1 Overview
    - 8.1.1.2.2 Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.3 Canada: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.2.4 Canada: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.3 Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.1 Overview
    - 8.1.1.3.2 Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.3 Mexico: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.3.4 Mexico: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
- 9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Grifols SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Pfizer Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Baxter International Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Fresenius Kabi AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Vifor Pharma Management AG
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Parenteral Nutrition Market Segmentation
Table 2. United States: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. United States: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 9. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. North America: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. United States: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. Canada: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. Mexico: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)